The Cost-effectiveness of Universal Self-injectable Epinephrine Auto-injector for Allergen Immunotherapy

This study evaluates the cost-effectiveness of universally prescribing SIE to AIT patients compared to a contextualized approach that offers SIE only to those with prior systemic reaction to immunotherapy (SRIT).

Source: Journal of Allergy and Clinical Immunology - January 31, 2020 Category: Allergy & Immunology Authors: Di Sun, Joseph Cafone, Marcus Shaker, Matthew Greenhawt Source Type: research